We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
Cap. Flow
+$7.27B
Cap. Flow %
9.7%
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.04B
2
MSFT icon
Microsoft
MSFT
+$830M
3
AMZN icon
Amazon
AMZN
+$550M
4
JNJ icon
Johnson & Johnson
JNJ
+$483M
5
AAPL icon
Apple
AAPL
+$470M

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Consumer Discretionary 13.75%
3 Healthcare 12.4%
4 Financials 7.81%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAT icon
2301
CALL
Caterpillar
CAT
$409B
$167K ﹤0.01%
+500
New +$173K
CTV.WS
2302
CALL
DELISTED
Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
$167K ﹤0.01%
90,000
-23,387
-21% -$1.54K
BANC icon
2303
Banc of California
BANC
$3.28B
$166K ﹤0.01%
+13,000
New +$180K
AVXL icon
2304
Anavex Life Sciences
AVXL
$222M
$166K ﹤0.01%
+39,351
New +$159K
VXRT
2305
DELISTED
Vaxart
VXRT
$166K ﹤0.01%
247,414
-285,665
-54% -$237K
ASM
2306
Avino Silver & Gold Mines
ASM
$987M
$165K ﹤0.01%
+183,601
New +$159K
TE
2307
T1 Energy
TE
$1.4B
$164K ﹤0.01%
96,449
-98,012
-50% -$187K
CION icon
2308
CION Investment
CION
$297M
$164K ﹤0.01%
+13,503
New +$159K
CLBK icon
2309
Columbia Financial
CLBK
$1.13B
$162K ﹤0.01%
+10,853
New +$168K
CLAR icon
2310
Clarus
CLAR
$125M
$161K ﹤0.01%
23,969
-20,860
-47% -$138K
OPI
2311
DELISTED
Office Properties Income Trust
OPI
$161K ﹤0.01%
+78,955
New +$172K
TARA icon
2312
Protara Therapeutics
TARA
$226M
$161K ﹤0.01%
+77,351
New +$226K
ENGNW icon
2313
CALL
enGene Therapeutics Warrants
ENGNW
$3.75M
$159K ﹤0.01%
16,813
-18,924
-53% -$60.6K
BW icon
2314
Babcock & Wilcox
BW
$1.43B
$157K ﹤0.01%
+108,233
New +$130K
CYPH
2315
Cypherpunk Technologies Inc
CYPH
$66.2M
$156K ﹤0.01%
79,758
+58,094
+268% +$152K
XBPEW
2316
CALL
XBP Europe Holdings Warrant
XBPEW
$156K ﹤0.01%
89,153
INVE icon
2317
Identive
INVE
$64.6M
$153K ﹤0.01%
35,503
-4,206
-11% -$20K
BAER icon
2318
Bridger Aerospace
BAER
$107M
$150K ﹤0.01%
40,212
-14,098
-26% -$61.5K
ACH
2319
Accendra Health
ACH
$240M
$150K ﹤0.01%
11,100
+3,077
+38% +$63K
VLRS
2320
Controladora Vuela Compania de Aviacion
VLRS
$876M
$150K ﹤0.01%
23,518
-3,495
-13% -$26.9K
TZOO icon
2321
Travelzoo
TZOO
$103M
$149K ﹤0.01%
19,669
-29,847
-60% -$254K
GROY icon
2322
Gold Royalty Corp
GROY
$593M
$148K ﹤0.01%
+104,637
New +$186K
GNL icon
2323
Global Net Lease
GNL
$1.87B
$147K ﹤0.01%
+19,990
New +$145K
LAB icon
2324
Standard BioTools
LAB
$326M
$144K ﹤0.01%
81,617
GSM icon
2325
FerroAtlántica
GSM
$628M
$144K ﹤0.01%
26,951
-481,922
-95% -$2.62M

Similar funds

Marshall Wace's Q2 2024 Portfolio in Review

As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.

  • Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
  • Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
  • Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
  • Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
  • Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.